Tirzepatide at Huemn CLINICAL EVIDENCE Tirzepatide for Weight Loss in Houston In the SURMOUNT-1 clinical trial, patients on the highest Tirzepatide dose lost an average of 22.5% of body weight at 72 weeks making it one of the most effective weight-loss medications studied to date
RA already raises cardiovascular risk, and GLP-1 medications are proven to reduce cardiovascular events in obesity and diabetes, with improved risk profiles seen in the RA study.
Typically, the dosage of semaglutide is escalated after 4 weeks, but microdosing may take longer
To support effective, long-lasting results, I recommend healthy Mediterranean-style nutrition, a regular program of strength training and cardio, good sleep hygiene, and stress reduction
You should always know which pharmacy is filling your prescription
By using medications like compounded tirzepatide as a tool within a broader program, you can achieve results that last